Product Information

POTASSIUM CL ER 10 MEQ TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0837 per EA under NDC 65862098799. Its NADAC has been published 351 times since Mar 4, 2020.

FDA first approved this application on Dec 19, 2018. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CL ER 10 MEQ TABLET

Potassium Chloride
$0.0837per EA

Strength

750 mg/1

NDC

65862098799

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

POTASSIUM CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA210921

FDA Approved

12/19/2018

TE Code

AB2

On Market Since

12/19/2018

Pharmacological Classes

Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Laxative
Potassium Compounds
Potassium Salt

Price Statistics

The NADAC for POTASSIUM CL ER 10 MEQ TABLET has been published 351 times since Mar 4, 2020, and over the history we have for it it has declined 49.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0837 per EA
All-time high$0.1784 (Nov 11, 2020)
All-time low$0.0828 (Sep 23, 2026)
52-week high$0.0943
52-week low$0.0828
Median price$0.1269
Average price$0.1251
Largest weekly change+35.0% (Aug 21, 2024)
Weeks tracked351
Tracking sinceMar 4, 2020

Price History

1W

-0.1%

1M

-0.1%

3M

-0.1%

6M

-5.2%

1Y

-5.9%

3Y

-35.2%

5Y

-42.0%

All

-49.5%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of POTASSIUM CL ER 10 MEQ TABLET?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 10 MEQ TABLET, manufactured by Aurobindo Pharma Limited, is $0.0837 per EA (NDC 65862098799), effective Nov 18, 2026.

How has the price of POTASSIUM CL ER 10 MEQ TABLET changed over time?

Over the history we have for it, the NADAC for POTASSIUM CL ER 10 MEQ TABLET has declined 49.5%. It has been tracked across 351 weekly CMS publications since Mar 4, 2020.

What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 10 MEQ TABLET?

Since Mar 4, 2020, the NADAC for POTASSIUM CL ER 10 MEQ TABLET has ranged from a low of $0.0828 (Sep 23, 2026) to a high of $0.1784 (Nov 11, 2020), with a median of $0.1269 per EA.

Are there cheaper alternatives to POTASSIUM CL ER 10 MEQ TABLET?

10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as POTASSIUM CL ER 10 MEQ TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures POTASSIUM CL ER 10 MEQ TABLET?

POTASSIUM CL ER 10 MEQ TABLET (NDC 65862098799) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.